Attenuation of Liver Stiffness in Sorafenib-Treated Patients With Advanced Hepatocellular Carcinoma

Hepatoma Research

doi 10.20517/2394-5079.2016.43

Full Text

Abstract

Available in

Date

Authors

Publisher

OAE Publishing Inc.

Related search

Early Α-Fetoprotein Response Predicts Survival in Patients With Advanced Hepatocellular Carcinoma Treated With Sorafenib

Journal of Hepatocellular Carcinoma
2015English

Post-Progression Survival and Progression-Free Survival in Patients With Advanced Hepatocellular Carcinoma Treated by Sorafenib

Hepatology Research
HepatologyInfectious Diseases
2015English

Long Duration of Stable Disease May Improve Overall Survival in Patients With Advanced Hepatocellular Carcinoma Treated With Sorafenib

Acta Hepatologica Japonica
Hepatology
2012English

Sorafenib Combined With Hepatectomy in Patients With Intermediate-Stage and Advanced Hepatocellular Carcinoma

Archives of Medical Science
Medicine
2017English

Advanced Hepatocellular Carcinoma: Pretreatment Contrast-Enhanced CT Texture Parameters as Predictive Biomarkers of Survival in Patients Treated With Sorafenib

Radiology
Nuclear MedicineRadiologyImaging
2018English

Sorafenib vs Nivolumab in Patients With Hepatocellular Carcinoma

Journal of Liver Research, Disorders & Therapy
2017English

Sorafenib-Induced Acute Interstitial Pneumonia in Patients With Advanced Hepatocellular Carcinoma: Report of Three Cases

Clinical Journal of Gastroenterology
MedicineGastroenterology
2012English

Phase I Trial of Sorafenib Following Liver Transplantation in Patients With High-Risk Hepatocellular Carcinoma.

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2015English

Addition of Local Hepatic Therapy to Sorafenib in Patients With Advanced Hepatocellular Carcinoma (Stage BCLC C)

Digestion
Gastroenterology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy